Nav: Home

New vaccine strategy better protects high-risk cancer patients from flu

December 06, 2015

New Haven, Conn. - Yale Cancer Center researchers have developed a vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza. The findings were presented Dec. 6 at the 57th annual meeting of the American Society of Hematology in Orlando, Florida.

Patients with cancers of the immune system, like multiple myeloma, are especially susceptible to common infections, and a bout of the flu can lead to serious illness and even death. Even though patients with multiple myeloma and other plasma cell disorders may receive an annual flu vaccine, studies show that a one-time flu shot does not offer adequate immune response.

The Yale researchers developed a strategy that entailed offering patients a high-dose flu vaccine followed by a second high-dose booster shot one month later. The high-dose vaccine (Fluzone High-Dose) was approved in 2009 by the FDA as a single dose for adults over 65.

The booster strategy lowered the flu infection rate among patients to 6% versus an expected rate of 20%, and it improved protection against all flu strains covered by the vaccine in 66% of patients, said the study's first author Andrew Branagan, M.D., a postdoctoral associate in medicine (hematology).

"Using an approved flu vaccine in a novel dosing schedule yielded promising results for a group patients at high risk for infection," Branagan said. "We hope to confirm these results in a larger prospective randomized trial that is underway now at Yale during the 2015-2016 flu season. We suspect this strategy could benefit other cancer patient populations."
-end-
This study was supported by the Arthur R. Sekerak Cancer Research Fund a Yale Cancer Center philanthropic fund.

Yale University

Related Multiple Myeloma Articles:

CAR T-Cell therapy sends multiple myeloma into lasting remission
In an early clinical trial, 33 out of 35 (94 percent) patients had clinical remission of multiple myeloma upon receiving a new type of immunotherapy -- chimeric antigen receptor (CAR) T cells targeting B-cell maturation protein or BCMA.
Using a rabbit virus to treat multiple myeloma
Treating multiple myeloma (MM) with myxoma virus (MYXV) eliminated a majority of malignant cells in preclinical studies, report investigators at the Medical University of South Carolina (MUSC) and elsewhere in an article published online on Dec.
Inhibition of EZH2 might be new therapy of multiple myeloma
In a study published in the scientific journal Oncotarget, researchers from Uppsala University show how the protein EZH2 affects the development of multiple myeloma, and that inhibition of EZH2 could be used as a new strategy to treat the disease.
Additions to standard multiple myeloma therapy do not appear to yield additional benefit
Trial results being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego suggest two therapies that are often added to standard therapy in patients with multiple myeloma do not improve rates of progression-free survival compared with the current standard course of treatment alone.
Early treatment may prevent progression to multiple myeloma
Early intervention with an immunotherapy-based drug combination may prevent progression of high-risk 'smoldering' multiple myeloma to the full-blown disease, according to researchers from Dana-Farber Cancer Institute.
Advances in multiple myeloma, lymphoma and other hematologic malignancies presented at ASH
Researchers from UH Seidman Cancer Center and Case Western Reserve University School of Medicine presented new findings in multiple myeloma, lymphoma and other hematologic disorders at Annual Meeting of American Society of Hematology.
Weight loss may help prevent multiple myeloma
Carrying extra weight increases a person's risk that a benign blood disorder will develop into multiple myeloma, a blood cancer.
Researchers take step toward understanding how multiple myeloma takes hold
Scientists are moving closer to understanding how multiple myeloma takes hold in bone marrow by identifying what they believe are the mechanisms used by cancer cells to take over.
Elotuzumab in multiple myeloma: Added benefit not proven
The only study presented was unsuitable for the benefit assessment.
As body mass index increases, so does spread of multiple myeloma
In a new study, American University researchers show how, as body mass index increases, so does the growth and spread of the blood cancer multiple myeloma.

Related Multiple Myeloma Reading:

The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones, Second Edition (Volume 2)
by Jim Tamkin MD FACP FACE (Author), Dave Visel (Author)

The Myeloma Survival Guide makes sense of the difficult questions myeloma patients face, dealing with every aspect of life after diagnosis, from creating a wellness team to navigating treatment options to building a financial safety net. Jim Tamkin, Md, who lived with myeloma for 11 years, and Dave Visel share the insights they've gained as a doctor, patient, and caregiver, including:

Everything you need to know about drugs and treatments, including stem cell transplantsHow to deal with the pain and side effects of chemotherapy, radiation, and surgeryInsurance and tax benefits to... View Details


100 Questions & Answers About Myeloma (100 Questions and Answers)
by Asad Bashey (Author), Rafat Abonour (Author), James W. Huston (Author)

EMPOWER YOURSELF!

Whether you're a newly diagnosed myeloma patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor's and patient's views, 100 Questions & Answers About Myeloma, Third Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a hematologist-oncologist specializing in myeloma treatment, and featuring "insider" advice from an actual patient, this book is an invaluable resource for anyone coping with the... View Details


A Lucky Life Interrupted: A Memoir of Hope
by Tom Brokaw (Author)

NEW YORK TIMES BESTSELLER • WITH A NEW PREFACE BY THE AUTHOR • A powerful memoir of a dramatic year spent battling cancer and reflecting on a long, happy, and lucky life—from the bestselling author of The Greatest Generation, whose iconic career in journalism has spanned more than fifty years

Tom Brokaw has led a fortunate life, with a strong marriage and family, many friends, and a brilliant journalism career culminating in his twenty-two years as anchor of the NBC Nightly News and as bestselling author. But in the summer of 2013, when... View Details


Understanding Multiple Myeloma
by Cristina Gasparetto (Author), Dharshan Sivaraj (Author)

EMPOWER YOURSELF!

Whether you've been recently diagnosed with multiple myeloma, are a survivor, or a friend or relative of either, this book provides a framework for patients, students, and health professionals alike to better understand the history, treatment, and behavior of the blood cancer multiple myeloma. As a patient, becoming informed about the nature and treatment of this disease can help facilitate a more active and supportive relationship with the healthcare team. Understanding Multiple Myeloma provides insight into where we have been, where we currently are, and where we... View Details


Multiple Myeloma: A Textbook for Nurses (Second Edition)
by Joseph Tariman (Author), Beth Faiman (Author)

The science of multiple myeloma is changing rapidly and this second edition provides nurses with the knowledge they need to stay informed and provide optimal care to a complex population of patients. The second edition of Multiple Myeloma: A Textbook for Nurses presents cutting-edge information on the treatment of multiple myeloma. New chapters discuss developments in genomics and biomarkers and promising clinical drug trials, covering major breakthroughs in clinical practice. View Details


Multiple Myeloma: Diagnosis and Treatment
by Morie A. Gertz (Editor), S. Vincent Rajkumar (Editor)

This is a comprehensive, state-of-the-art guide to the diagnosis, treatment, and biology of multiple myeloma and related plasma disorders. Edited and written by a multidisciplinary group of recognized authorities from the Mayo Clinic, it presents clear guidelines on diagnosis and therapy and covers all aspects of multiple myeloma, from molecular classification and diagnosis, to risk stratification and therapy. Closely related plasma cell disorders such as solitary plasmacytoma, Waldenstrom macroglobulinemia, and light chain amyloidosis are discussed in detail as well. The book addresses... View Details


Multiple Myeloma Patient Handbook: 2017 Edition
by International Myeloma Foundation

One of the most daunting aspects of being diagnosed with myeloma is learning about an unfamiliar disease that is quite complicated. The IMF’s Patient Handbook provides an overview of myeloma, with a focus on getting the correct diagnosis, the tests you really need, initial treatment options, and supportive care and how to get it. View Details


Multiple Myeloma: The Plain English Handbook for Patients and Care Givers
by Robert J. Heller (Author)

A comprehensive handbook and guide in easy to understand terms dealing with Multiple Myeloma; the disease, treatments, medications, lifestyle changes, and resources. Written by a non-medical author and based upon personal experiences. Updated annually. View Details


The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones
by Jim Tamkin MD FACP FACE (Author), Dave Visel (Author)

The definitive guide to living a longer, fuller life with myeloma

The Myeloma Survival Guide makes sense of the difficult questions myeloma patients face, dealing with every aspect of life after diagnosis, from creating a wellness team to navigating treatment options to building a financial safety net. Jim Tamkin, MD, who lived with myeloma for 11 years, and Dave Visel share the insights they've gained as a doctor, patient, and caregiver, including:

Everything you need to know about drugs and treatments, including stem cell transplants How to deal with the pain and... View Details


Battle Against Multiple Myeloma: A true story by the cancer survivor
by Sreedharan C K (Author)

‘Battle Against Multiple Myeloma- A true story by the cancer survivor,’ is an attempt by the author to share his real life trauma and his own personal experience in battling with the dreaded disease. In this book the author covers all aspects of the disease right from the detection to treatment. A distinguishing feature of this book is the sharing of actual medical and laboratory reports of the author, which helps in the clear understanding. The author also provides extensive information on cancer prevention and ways to strengthen the immune system of the body. The immune system is the... View Details

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

The Big Five
What are the five biggest global challenges we face right now — and what can we do about them? This hour, TED speakers explore some radical solutions to these enduring problems. Guests include geoengineer Tim Kruger, president of the International Rescue Committee David Miliband, political scientist Ian Bremmer, global data analyst Sarah Menker, and historian Rutger Bregman.
Now Playing: Science for the People

#456 Inside a Conservation NGO
This week we take a close look at conservation NGOS: what they do, how they work, and - most importantly - why we need them. We'll be speaking with Shyla Raghav, the Climate Change Lead at Conservation International, about using strategy and policy to tackle climate change. Then we'll speak with Rebecca Shaw, Lead Scientist at the World Wildlife Fund, about how and why you should get involved with conservation initiatives.